Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022

SELL
$2.46 - $5.2 $39,027 - $82,498
-15,865 Reduced 98.77%
198 $1,000
Q4 2021

Feb 02, 2022

SELL
$7.65 - $11.38 $443 - $660
-58 Reduced 0.36%
16,063 $137,000
Q3 2021

Nov 02, 2021

SELL
$9.93 - $13.59 $36,393 - $49,807
-3,665 Reduced 18.52%
16,121 $187,000
Q2 2021

Aug 02, 2021

BUY
$11.87 - $15.96 $27,134 - $36,484
2,286 Added 13.06%
19,786 $248,000
Q1 2021

May 11, 2021

BUY
$13.87 - $21.04 $59,641 - $90,472
4,300 Added 32.58%
17,500 $243,000
Q4 2020

Feb 08, 2021

BUY
$17.03 - $22.45 $112,398 - $148,170
6,600 Added 100.0%
13,200 $262,000
Q3 2020

Nov 05, 2020

BUY
$19.3 - $26.92 $127,380 - $177,672
6,600 New
6,600 $151,000

About Akouos, Inc.


  • Ticker AKUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,929,000
  • Description
  • Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...
More about AKUS
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.